Literature DB >> 17938577

Downregulation of IgG Fc binding protein (Fc gammaBP) in prostate cancer.

Mozammel H Gazi1, MeiLan He, John C Cheville, Charles Y F Young.   

Abstract

By means of protein expression profile, mass spectral and/or RT-PCR analyses we found for the first time IgG Fc binding protein (Fc gammaBP), distinct from Fc gamma receptors is expressed in both human and mouse prostates. There is a strong correlation between downregulation of Fc gammaBP and the progression of prostate cancer in Transgenic Adenocarcinoma Mouse Prostate (TRAMP) mice. Fc gammaBP gene expression is significantly reduced or lost in human prostate tumor tissues and prostate cell lines. The differentially expressed Fc gammaBP could reflect its potential role in prostate malignancy as well as an indicator for progression of the cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17938577     DOI: 10.4161/cbt.7.1.5131

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  13 in total

1.  Copy number variation analysis reveals additional variants contributing to endometriosis development.

Authors:  Fernanda Mafra; Diego Mazzotti; Renata Pellegrino; Bianca Bianco; Caio Parente Barbosa; Hakon Hakonarson; Denise Christofolini
Journal:  J Assist Reprod Genet       Date:  2016-11-05       Impact factor: 3.412

2.  Small molecule inhibition of cytoskeletal dynamics in melanoma tumors results in altered transcriptional expression patterns of key genes involved in tumor initiation and progression.

Authors:  Carrie Spencer; John Montalvo; Sarah R McLaughlin; Brad A Bryan
Journal:  Cancer Genomics Proteomics       Date:  2011 Mar-Apr       Impact factor: 4.069

3.  Prognostic and immunological roles of Fc fragment of IgG binding protein in colorectal cancer.

Authors:  Qunchuan Zhuang; Aling Shen; Liya Liu; Meizhu Wu; Zhiqing Shen; Huixin Liu; Ying Cheng; Xiaoying Lin; Xiangyan Wu; Wei Lin; Jiapeng Li; Yuying Han; Xiaoping Chen; Qi Chen; Jun Peng
Journal:  Oncol Lett       Date:  2021-05-13       Impact factor: 2.967

4.  Identification and validation of genes involved in cervical tumourigenesis.

Authors:  Thangarajan Rajkumar; Kesavan Sabitha; Neelakantan Vijayalakshmi; Sundersingh Shirley; Mayil Vahanan Bose; Gopisetty Gopal; Ganesharaja Selvaluxmy
Journal:  BMC Cancer       Date:  2011-02-22       Impact factor: 4.430

5.  Identifying potential biomarkers related to pre-term delivery by proteomic analysis of amniotic fluid.

Authors:  Subeen Hong; Ji Eun Lee; Yu Mi Kim; Yehyon Park; Ji-Woong Choi; Kyo Hoon Park
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

6.  IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer Patients.

Authors:  Ziming Yuan; Zhixun Zhao; Hanqing Hu; Yihao Zhu; Weiyuan Zhang; Qingchao Tang; Rui Huang; Feng Gao; Chaoxia Zou; Guiyu Wang; Xishan Wang
Journal:  Onco Targets Ther       Date:  2021-02-11       Impact factor: 4.147

7.  A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.

Authors:  Kai Wang; Chenan Guan; Xianwen Shang; Xiang Ying; Shuangshuang Mei; Hanxiao Zhu; Liang Xia; Zeying Chai
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

8.  Adipose Tissue Epigenetic Profile in Obesity-Related Dysglycemia - A Systematic Review.

Authors:  Sara Andrade; Tiago Morais; Ionel Sandovici; Alexandre L Seabra; Miguel Constância; Mariana P Monteiro
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-29       Impact factor: 5.555

9.  Fcgbp - A Potential Viral Trap in RV144.

Authors:  Jacquelyn L Schwartz
Journal:  Open AIDS J       Date:  2014-09-08

10.  FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma.

Authors:  Tengfeng Yan; Daofeng Tian; Junhui Chen; Yinqiu Tan; Yue Cheng; Liguo Ye; Gang Deng; Baohui Liu; Fanen Yuan; Shenqi Zhang; Linzhi Cai; Qianxue Chen
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.